MoneyWorks4Me

Zim Laboratories - Quaterly Results

26 Jul 2022 Evaluate
The sales for the June 2022 quarter moved up 45.35% to Rs. 925.03 millions as compared to Rs. 636.40 millions during the corresponding quarter last year.Net Profit for the quarter ended June 2022 zoomed to 2933.33% from Rs. 1.86 millions to Rs. 56.42  millions.Operating profit surged to 132.52 millions from the corresponding previous quarter of 61.80 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 925.03 636.40 45.35 925.03 636.40 45.35 3294.94 3036.29 8.52
Other Income 18.73 12.51 49.72 18.73 12.51 49.72 45.06 24.49 83.99
PBIDT 132.52 61.80 114.43 132.52 61.80 114.43 424.40 392.62 8.09
Interest 13.31 25.46 -47.72 13.31 25.46 -47.72 83.06 108.86 -23.70
PBDT 119.21 36.34 228.04 119.21 36.34 228.04 341.34 231.95 47.16
Depreciation 39.51 33.64 17.45 39.51 33.64 17.45 148.37 146.14 1.53
PBT 79.70 2.70 2851.85 79.70 2.70 2851.85 192.97 85.81 124.88
TAX 23.28 0.84 2671.43 23.28 0.84 2671.43 62.84 29.64 112.01
Deferred Tax 9.95 0.63 1479.37 9.95 0.63 1479.37 28.84 29.47 -2.14
PAT 56.42 1.86 2933.33 56.42 1.86 2933.33 130.13 56.17 131.67
Equity 162.42 162.42 0.00 162.42 162.42 0.00 162.42 162.42 0.00
PBIDTM(%) 14.33 9.71 47.52 14.33 9.71 47.52 12.88 12.93 -0.39
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..